Celularity
Celularity is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.
Domain
celularity.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$10.0M
Founded
2017
Tech Stack (21 technologies)
Frequently Asked Questions
What technologies does Celularity use?+
Celularity uses 21 technologies including Google Analytics, Google Tag Manager, Hammer.js.
What industry is Celularity in?+
Celularity operates in the Biotechnology industry.
Where is Celularity based?+
Celularity is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026